. 2021 Jul 16;21:1409. doi: 10.1186/s12889-021-11464-7

Table 3.

Standardized Prevalence Rates of Multimorbidity – prevalence rates are standardised for sex and ethnicity

	0–24 years		25–44 years		45–64 years		65–99 years
	CPR^d, %	ASE SPR^a, % (CI^c)	CPR^d, %	ASE SPR^a % (CI^c)	CPR^d, %	ASE SPR^a, % (CI^c)	CPR^d, %	ASE SPR^a, % (CI^c)
CDMP^b MM^e2⁺	0.16	0.13 (0.12, 0.15)	5.3	5.8 (5.6, 5.9)	40.6	37.8 (37.6, 38.1)	72.7	72.5 (72.0, 72.9)
CDMP^b MM^e3⁺	0.02	0.01 (0.01, 0.02)	1.7	1.9 (1.8, 2.0)	21.0	19.1 (18.9, 19.3)	49.9	49.7 (49.4, 50.0)
Fortin MM^e2⁺	0.73	0.61 (0.58, 0.65)	8.1	8.9 (8.7, 9.0)	48.2	45.3 (45.1, 45.6)	77.5	77.3 (76.9, 77.7)
Fortin MM^e3⁺	0.11	0.08 0.07, 0.10)	3.7	4.0 (3.9, 4.1)	30.9	28.5 (28.3, 28.7)	61.1	60.9 (60.5, 61.2)

^a ASE SPR Age-stratified, sex-and-ethnicity standardized prevalence rate, ^b CDMP Chronic Disease Management Programme, ^c CI Confidence interval, ^d CPR Crude prevalence rate, ^e MM Multimorbidity